A citation-based method for searching scientific literature

Desmond Y H Yap, Colin Tang, Gary C W Chan, Lorraine P Y Kwan, Maggie K M Ma, Maggie M Y Mok, Tak Mao Chan. J Rheumatol 2018
Times Cited: 23







List of co-cited articles
174 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis,[...]. Lancet 2018
160
56

Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience.
Desmond Y H Yap, Maggie K M Ma, Colin So Tang, Tak Mao Chan. Nephrology (Carlton) 2012
30
30

Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
Sing Leung Lui, Ryan Tsang, Kwok Wah Chan, Florence Zhang, Sidney Tam, Susan Yung, Tak Mao Chan. Nephrol Dial Transplant 2008
57
30

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
David Fernandez, Eduardo Bonilla, Naureen Mirza, Brian Niland, Andras Perl. Arthritis Rheum 2006
204
26


Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
S L Lui, S Yung, R Tsang, F Zhang, K W Chan, S Tam, T M Chan. Lupus 2008
42
21


Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus.
Per Eriksson, Philip Wallin, Christopher Sjöwall. Front Pharmacol 2019
21
23

The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin.
Kostas Stylianou, Ioannis Petrakis, Vasiliki Mavroeidi, Stavros Stratakis, Eleftheria Vardaki, Kostas Perakis, Spyros Stratigis, Andreas Passam, Eva Papadogiorgaki, Kostas Giannakakis,[...]. Nephrol Dial Transplant 2011
59
17

Survival analysis and causes of mortality in patients with lupus nephritis.
Desmond Y H Yap, Colin S O Tang, Maggie K M Ma, Man Fai Lam, Tak Mao Chan. Nephrol Dial Transplant 2012
128
17


Immunometabolism in systemic lupus erythematosus.
Laurence Morel. Nat Rev Rheumatol 2017
102
17

N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily,[...]. Arthritis Rheum 2012
208
17

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Christian Lood, Luz P Blanco, Monica M Purmalek, Carmelo Carmona-Rivera, Suk S De Ravin, Carolyne K Smith, Harry L Malech, Jeffrey A Ledbetter, Keith B Elkon, Mariana J Kaplan. Nat Med 2016
602
17

Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters.
Wei Li, Ganlin Qu, Seung-Chul Choi, Caleb Cornaby, Anton Titov, Natalie Kanda, Xiangyu Teng, Haiting Wang, Laurence Morel. Front Immunol 2019
39
17

Normalization of CD4+ T cell metabolism reverses lupus.
Yiming Yin, Seung-Chul Choi, Zhiwei Xu, Daniel J Perry, Howard Seay, Byron P Croker, Eric S Sobel, Todd M Brusko, Laurence Morel. Sci Transl Med 2015
304
17

Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
David R Fernandez, Tiffany Telarico, Eduardo Bonilla, Qing Li, Sanjay Banerjee, Frank A Middleton, Paul E Phillips, Mary K Crow, Stefanie Oess, Werner Muller-Esterl,[...]. J Immunol 2009
154
17

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
17

CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Tomohiro Koga, Christian M Hedrich, Masayuki Mizui, Nobuya Yoshida, Kotaro Otomo, Linda A Lieberman, Thomas Rauen, José C Crispín, George C Tsokos. J Clin Invest 2014
116
17

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Zachary Oaks, Thomas Winans, Nick Huang, Katalin Banki, Andras Perl. Curr Rheumatol Rep 2016
43
13

Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Zhi-Wei Lai, Rebecca Borsuk, Ashwini Shadakshari, Jianghong Yu, Maha Dawood, Ricardo Garcia, Lisa Francis, Hajra Tily, Adam Bartos, Stephen V Faraone,[...]. J Immunol 2013
77
13

Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.
Elizabeth L Yanik, Kulsoom Siddiqui, Eric A Engels. Cancer Med 2015
62
13

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Karen L Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P Lambert, Jack J Bleesing, Alix E Seif, Catherine S Manno, James Casper, Stephan A Grupp, David T Teachey. Blood 2016
97
13

Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Guillaume Canaud, Frank Bienaimé, Fanny Tabarin, Guillaume Bataillon, Danielle Seilhean, Laure-Hélène Noël, Marie-Agnès Dragon-Durey, Renaud Snanoudj, Gérard Friedlander, Lise Halbwachs-Mecarelli,[...]. N Engl J Med 2014
175
13

Rapamycin for refractory discoid lupus erythematosus.
Mitchell Herold, Nicholas A Richmond, Michael A Montuno, Stanton K Wesson, Kiran Motaparthi. Dermatol Ther 2018
8
37

Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
Desmond Y H Yap, Colin Tang, Maggie K M Ma, Maggie M Y Mok, Gary C W Chan, Lorraine P Y Kwan, Tak Mao Chan. J Rheumatol 2017
18
16


Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
Tak-Mao Chan, Kai-Chung Tse, Colin Siu-On Tang, Mo-Yin Mok, Fu-Keung Li. J Am Soc Nephrol 2005
313
13

Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism.
Tao Xu, Kelly M Stewart, Xiaohu Wang, Kai Liu, Min Xie, Jae Kyu Ryu, Ke Li, Tianhua Ma, Haixia Wang, Lu Ni,[...]. Nature 2017
142
13

Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.
Georgia McDonald, Shantal Deepak, Laura Miguel, Cleo J Hall, David A Isenberg, Anthony I Magee, Terry Butters, Elizabeth C Jury. J Clin Invest 2014
85
13

Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin.
Andras Perl, Robert Hanczko, Zhi-Wei Lai, Zachary Oaks, Ryan Kelly, Rebecca Borsuk, John M Asara, Paul E Phillips. Metabolomics 2015
67
13

Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.
Michihito Kono, Nobuya Yoshida, Kayaho Maeda, George C Tsokos. Proc Natl Acad Sci U S A 2018
39
13

Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.
Mako Nakaya, Yichuan Xiao, Xiaofei Zhou, Jae-Hoon Chang, Mikyoung Chang, Xuhong Cheng, Marzenna Blonska, Xin Lin, Shao-Cong Sun. Immunity 2014
391
13



Metformin Inhibits the Type 1 IFN Response in Human CD4+ T Cells.
Anton A Titov, Henry V Baker, Todd M Brusko, Eric S Sobel, Laurence Morel. J Immunol 2019
20
15

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
T M Chan, F K Li, C S Tang, R W Wong, G X Fang, Y L Ji, C S Lau, A K Wong, M K Tong, K W Chan,[...]. N Engl J Med 2000
688
13

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
Lewis Z Shi, Ruoning Wang, Gonghua Huang, Peter Vogel, Geoffrey Neale, Douglas R Green, Hongbo Chi. J Exp Med 2011
13


Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta,[...]. Arthritis Rheum 2012
706
13

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Chi Chiu Mok, King Yee Ying, Cheuk Wan Yim, Yui Pong Siu, Ka Hang Tong, Chi Hung To, Woon Leung Ng. Ann Rheum Dis 2016
106
13

Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Zhihong Liu, Haitao Zhang, Zhangsuo Liu, Changying Xing, Ping Fu, Zhaohui Ni, Jianghua Chen, Hongli Lin, Fuyou Liu, Yongcheng He,[...]. Ann Intern Med 2015
173
13

ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity.
Jared M Odegard, Benjamin R Marks, Leah D DiPlacido, Amanda C Poholek, Dwight H Kono, Chen Dong, Richard A Flavell, Joe Craft. J Exp Med 2008
282
13

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
739
13

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Brad H Rovin, Neil Solomons, William F Pendergraft, Mary Anne Dooley, James Tumlin, Juanita Romero-Diaz, Lidia Lysenko, Sandra V Navarra, Robert B Huizinga. Kidney Int 2019
83
13

Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
Richard Furie, Kathy Nicholls, Tien-Tsai Cheng, Frederic Houssiau, Ruben Burgos-Vargas, Shun-Le Chen, Jan L Hillson, Stephanie Meadows-Shropshire, Michael Kinaszczuk, Joan T Merrill. Arthritis Rheumatol 2014
193
13

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
804
13

Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Tomohiro Koga, Tomohito Sato, Kaori Furukawa, Shimpei Morimoto, Yushiro Endo, Masataka Umeda, Remi Sumiyoshi, Shoichi Fukui, Shin-Ya Kawashiri, Naoki Iwamoto,[...]. Arthritis Rheumatol 2019
14
21

Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Michihito Kono, Nobuya Yoshida, Kayaho Maeda, Abel Suárez-Fueyo, Vasileios C Kyttaris, George C Tsokos. Arthritis Rheumatol 2019
26
13

Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.
Michihito Kono, Nobuya Yoshida, Kayaho Maeda, Nicole E Skinner, Wenliang Pan, Vasileios C Kyttaris, Maria G Tsokos, George C Tsokos. Proc Natl Acad Sci U S A 2018
25
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.